Human growth hormone (hGH, Somatotropin) is one of growth hormones which are synthesized in the anterior lobe of the pituitary gland and has a major action in promoting somatic growth. It is a protein of M. W. 22,000 daltons (referred to as 22K hGH), consisting of a single polypeptide chain of 191 amino acids with two disulfide cross-linking bridges (Wallis, 1978) .
There are two other hGH-related hormones, chorionic somatomammotropin (hCS; placental lactogen) and human prolactin (hPRL), which have been classified into the same family as hGH, and hGH shares 85% of amino acid residues with hCS but only 16% with hPRL (reviewed by Wallis, 1978) .
The assay of hGH is important in clinics in diagnosing hyperpituitarism, acromegary and hGH deficiency (dwarfism). The level of hGH in serum has been routinely measured by radioimmunoassay (RIA) and enzyme immunoassay (EIA) using rabbit antiserum to hGH. From the homology of amino acid residues among hGH, hCS and hPRL, anti-hGH serum would be expected to crossreact with hCS at a high rate, but not with hPRL. In practice, however, a strong crossreaction between hGH and hPRL has been observed at a relatively high frequency because the hGH preparation for immunization has often been contaminated with hPRL (Hwang et al., 1971 ). An antibody with a high specificity should be applied to clinical diagnosis of hGH in order to accurately measure the level of hGH in body fluid.
Furthermore, recent studies showed that there is a native variant of hGH in human serum or in the anterior lobe of the pituitary gland (Lewis et al., 1978 (Lewis et al., , 1980 . It is composed of 176 amino acids and referred to as 20K hGH.
Although 20K hGH lacks the early insulin-like and intrinsic diabetogenic activities of 22K hGH, it shows the same order of growth promoting activity as 22K hGH (Lewis et al., 1980) . In this point, the selective assay of 22K hGH discriminating it from 20K hGH would be important in diagnostics and basic research on this hormone.
A hybridoma technique established by Kohler and Milstein (1975) Screening Screening was done 10-12 days after fusion and also 10-12 days after cloning by means of modified ELISA methods (Engvall and Perlmann, 1972) . Briefly, hGH (100ng/well) dissolved in PBS (pH7.2) was adsorbed to polyvinylchloride 96-well microplate (Falcon Microtest III flexible assay plate, Becton Dickinson, Oxnard, CA) and then blocked with 1% (w/v) BSA in PBS (pH 7.2). Culture media of hybrids and alkaline phosphatase (ALP) labelled anti-mouse immunoglobulin antibody (New England Nuclear, Boston, MA) with 1% (w/v) BSA in PBST (0.05% (w/v) Tween-20 in PBS PH 7.2) were added to the plate sequentially.
The reaction was quantitated by adding substrate of pnitrophenylphosphate disodium and reading the optical density at 405nm in a Titerteck Multiskan automated spectrophotometer MCC (Flow Laboratories, McLean Virginia). anti-mouse Ig (NEN). The reaction was quantitated by adding the substrate and reading the optical density at 405nm in a Titerteck Multiskan automated spectrophotometer.
Results

Cell fusion
In successful fusions, colony growth of hybrids was observed in 100% wells of a 96-well microplate used and a positive antihGH antibody titre (more than 5-10 fold higher radioactivity in 125I-hGH co-precipitated than that of background in the RIA system) was detected in 35% of a total of 170 wells. Then cells in the antibody titre-positive wells were cloned and (Bundesen et al ., 1980; Ivanyi and Davis, 1980; Jonsdottir et al ., 1981 Jonsdottir et al ., , 1983 Retegui et al ., 1982) . They characterized the binding affinity and binding specificity (cross reactivity) of McAbs . However, little has been studied about the binding sites recognized by the McAbs . In this paper, we have examined specific binding sites using fragments and variants of hGH and have classified at least two groups of McAbs recognizing different epitopes of hGH.
Five out of 13 McAbs, such as 1D2, bound to fragment F1, indicating that these McAbs would mainly recognize an epitope located at the N-terminal two-third part of hGH. In contrast, the other McAbs such as CL.B1 did not bind to either F 1 or F2 although CL.B1 bound to S2 and a3 variants as well as native hGH at high affinity . The binding affinity of CL.B1 to 20K hGH variant was one twenty-sixth of that of CL.B1 to 22K hGH.
In addition, 1D2 (the former group) slightly bound to reduced and alkylated 22K hGH, but CL.B1 (the latter group) did not bind at all in Western blotting (data not shown). A line of evidence strongly suggests that CL.B1 would recognize the three-dimensional structure of hGH rather than a sequence of amino acid residues in the C-terminal one-third part of hGH.
Recently, a model three-dimensional structure of hGH was proposed (Cohen and Kuntz, 1987) , and confirmed by using genetically engineered variants of porcine growth hormone (Abdel-Meguid et al., 1987) (Hashida et al., 1988) .
